Re gesi Regenerative Medical Materials: First Prize of Direct Silicon Valley Entrepreneurship Competition and Team Group
Project Description: Regesi regenerative medicine new material is the only regenerative medicine material that can bond bone and soft tissue cells at the same time. Can be widely used in artificial bone, artificial skin, no scar after wound healing, permanent tooth repair, uterine repair and other fields 10.
Regards Regenerative Medicine New Material is a scientific and technological achievement with independent intellectual property rights held by Happy Life Company, which is a major breakthrough in key technologies in the field of regenerative medicine materials in the past 30 years.
The birth of new Regesi regenerative medical materials broke GSK's monopoly position in this field. At present, it has obtained more than 60 clinical trial reports, national authoritative certification and honors, 15 invention patents and 2 international patents, and passed the US FDA filing and EU CE certification.
Mankind's infinite pursuit of healthy, beautiful and high-quality life doomed the enduring market of medical beauty. And "Regesi Regenerative Medicine New Materials" can not only provide great convenience for medical treatment, but also add new vitality to the beauty market.
Regesi regenerated medical materials changed the order of silicon bonds, changed the melting of calcium and phosphorus, and changed the ecological environment of human cell repair and regeneration.
The material solves the problem that the sequence of silicon bonds is consistent with the three-dimensional network structure of human bones and soft tissues, the calcium-phosphorus ratio of important components of human bones is consistent, and the scaffold function of human bones and soft tissues cell regeneration is realized. The degradation rate of new cells and implanted materials is synchronous, so that the new cells are almost the same as the original cells.
Although the Regesi Regenerative Medical Materials Project was divided into "team groups" in this All-Silicon Valley Innovation and Entrepreneurship Competition, the teams that make up this project are not ordinary. On the contrary, its lineup is so powerful that people are dumbfounded! If nothing else, only 16 scientists and academicians in related fields can't be described as "average"! Not to mention the strategic cooperation between the four state key laboratories.
This project is a scientific and technological achievement with independent intellectual property rights held by Happy Life Company. As the only enterprise in the world that mass-produces this new regenerative medicine material, Beijing Happy Life High-tech Co., Ltd. has more than 60 clinical reports, authoritative certification, honors, 30 invention patents and 2 international patents, and has been selected into 4 national pharmaceutical product management catalogues.
Mr. Hu Fang, the founder and chairman of the company, is one of the "Top 50 Influential Enterprises in Beijing" and was awarded the honorary title of "China Craftsman" in China Entrepreneur Boao Forum on June 5438+February 65438+March 20 14.
Both the project and the founder have many honors, which on the one hand reflects the professionalism and reliability of the project, and on the other hand reflects the market's optimism about the project.
Regenerated medical materials are the demand of biotherapy in the world. It is estimated that in 2020, the output value of regenerative medical materials will be 600 billion US dollars, and the market demand for derived high-tech regenerative medical products will be 3 trillion US dollars.
The market demand of functional cosmetics for regenerative medicine and biotherapy in China exceeds 654.38+08 billion yuan, increasing at the rate of 654.38+00% every year.
A series of high-tech products developed with new materials of Regenerative Medicine of Reggaxi are expected to have an output value of over 654.38+0 billion yuan, which will be sold to developed countries and regions such as the United States, Japan, South Korea and Germany. It is estimated that the annual market demand will be above 6,543,800 tons. At present, the retail price of new materials for Regenerative Medicine in Rigsey is 4 million yuan/ton.
This project can be applied to:
Orthopedics: Biodegradable artificial bone materials will replace all artificial bone materials in the market. The market demand of this industry is around 200 billion yuan.
Dental implants: dental implants, enamel restoration, etc. The market demand for prosthodontics is about 654.38 billion yuan.
Scarless wound repair: accelerate wound healing, and no scar repair after wound healing. The proportion of caesarean section is as high as 30%, and the amount of operation is 5 1 10,000/year. The market capacity of scar-free wound repair is nearly 1 100 million yuan.
Medical beauty: medical beauty, biotherapy, beauty cosmetics, etc. It is estimated that the sales volume of Regesi regenerative medical materials will reach 65,438+0,000 tons in the future.
Tissue engineering: scaffold materials (degradable heart stents), artificial blood vessels, cornea, organ filling and other fields.
"20 17 China [Tianjin Beichen] Direct Access to Silicon Valley Competition" slightly emphasized industries such as intelligent manufacturing, biomedicine, new materials and new financial services, and expected that these industries would bring new breakthroughs to the market. "regesi Regenerative Medicine New Materials" will have a certain impact on the market and bring new breakthroughs, whether in the medical field or in the field of new materials!